Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders
Type
Physical Book
Publisher
Language
English
Pages
553
Format
Hardcover
ISBN13
9780128137062
Edition No.
1

Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders

Nussinovitch Udi (Author) · Academic Press · Hardcover

Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders - Nussinovitch Udi

New Book

£ 141.30

£ 157.00

You save: £ 15.70

10% discount
  • Condition: New
It will be shipped from our warehouse between Thursday, June 27 and Tuesday, July 02.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Emerging Technologies for Heart Diseases: Volume 1: Treatments for Heart Failure and Valvular Disorders"

The increasing pace of advances in cardiology throughout the last few decades has fundamentally altered the natural course of heart patients. In the last few years, available therapies have been revolutionized completely by new transcatheter therapeutic approaches, novel ventricular assist devices, and new drugs. Also, molecular biology and genetics have a rapidly growing impact on cardiovascular diseases, enabling the field of regenerative medicine to become increasingly closer to routine clinical implementation. Emerging Technologies for Heart Diseases was conceived to cover the recent extensive literature on current and novel therapeutic options for cardiac patients. The first volume is dedicated to heart failure and valvular disorders, and the second covers myocardial ischemia and arrhythmias. The clinical topic is addressed in several chapters divided according to the therapeutic approach (mechanical or electrical device-based, or cell and gene-based). Each of the 46 chapters focuses on clinically available solutions, new therapies currently under evaluation in clinical trials, promising preclinical technologies, and emerging concepts and innovations that have not yet been tested in a preclinical model. Also, the book discusses future challenges and opportunities for clinical implementation. Lessons learned from abandoned experimental practices are also covered, giving the readers the widest possible perspective of current therapeutic dilemmas. Overall, this textbook was designed for physicians who want to stay up-to-date with current therapies and those of the future, for biomedical companies, and for those who wish to broaden their knowledge of new cardiovascular therapeutic options.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews